Cargando…

Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer

MicroRNAs, a kind of small non-coding RNAs, can regulate gene expression by targeting mRNAs for translational repression or degradation. Much evidence has suggested that miR-218 was a tumor suppressor in many human cancers including prostate cancer. However, the underlying role of miR-218 in tumor a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Bing, Wu, Kaijie, Zeng, Jin, Xu, Shan, Mu, Lijun, Gao, Yang, Wang, Ke, Ma, Zhenkun, Tian, Juanhua, Shi, Qi, Guo, Peng, Wang, Xinyang, He, Dalin, Du, Yuefeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352391/ https://www.ncbi.nlm.nih.gov/pubmed/28030804 http://dx.doi.org/10.18632/oncotarget.14131

Ejemplares similares

Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer
por: Guan, Bing, et al.
Publicado: (2022)

MicroRNA-218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2
por: Mu, Lijun, et al.
Publicado: (2020)

MicroRNA-218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2
por: Mu, Lijun, et al.
Publicado: (2022)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Autophagy Induction by Silibinin Positively Contributes to Its Anti-Metastatic Capacity via AMPK/mTOR Pathway in Renal Cell Carcinoma
por: Li, Feng, et al.
Publicado: (2015)

Pharmacological vitamin C inhibits mTOR signaling and tumor growth by degrading Rictor and inducing HMOX1 expression
por: Qin, Senlin, et al.
Publicado: (2023)

mTOR Signaling Components in Tumor Mechanobiology
por: Gargalionis, Antonios N., et al.
Publicado: (2022)

Interaction between NBS1 and the mTOR/Rictor/SIN1 Complex through Specific Domains
por: Wang, Jian-Qiu, et al.
Publicado: (2013)

Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma
por: Benavides-Serrato, Angelica, et al.
Publicado: (2017)

Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1α signaling
por: DU, YUEFENG, et al.
Publicado: (2015)

Correction: Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma
por: Benavides-Serrato, Angelica, et al.
Publicado: (2019)

Retraction: Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma
Publicado: (2023)

RICTOR/mTORC2 affects tumorigenesis and therapeutic efficacy of mTOR inhibitors in esophageal squamous cell carcinoma
por: Lu, Zhaoming, et al.
Publicado: (2020)

Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma
por: Lamanuzzi, Aurelia, et al.
Publicado: (2018)

G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell Carcinoma
por: Li, Feng, et al.
Publicado: (2015)

RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR
por: Sakre, Nneha, et al.
Publicado: (2016)

Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1
por: Luciano, Amelia K., et al.
Publicado: (2022)

Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors
por: Chou, Wen-Chi, et al.
Publicado: (2016)

Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models
por: Schmidt, Katharina M., et al.
Publicado: (2017)

mTOR and Tumor Cachexia
por: Duval, Adrian P., et al.
Publicado: (2018)

Insulin-like growth factor binding protein-3 mediates interleukin-24-induced apoptosis through inhibition of the mTOR pathway in prostate cancer
por: DU, YUEFENG, et al.
Publicado: (2015)

Platelet-derived growth factor-induced Akt phosphorylation requires mTOR/Rictor and phospholipase C-γ1, whereas S6 phosphorylation depends on mTOR/Raptor and phospholipase D
por: Razmara, Masoud, et al.
Publicado: (2013)

The expression and function of RASAL2 in renal cell carcinoma angiogenesis
por: Hui, Ke, et al.
Publicado: (2018)

Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancer
por: Ruder, Dennis, et al.
Publicado: (2018)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

A shift of the TOR adaptor from Rictor towards Raptor by semaphorin in C. elegans
por: Nukazuka, Akira, et al.
Publicado: (2011)

MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression
por: Oneyama, Chitose, et al.
Publicado: (2013)

Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus
por: Zhang, Tingting, et al.
Publicado: (2015)

PI3K/AKT/mTOR Pathway in Angiogenesis
por: Karar, Jayashree, et al.
Publicado: (2011)

microRNA-153 Targets mTORC2 Component Rictor to Inhibit Glioma Cells
por: Cui, Yan, et al.
Publicado: (2016)

Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors
por: Yim, Kein-Leong
Publicado: (2012)

Targeting the mTOR Signaling Pathway in Neuroendocrine Tumors
por: Chan, Jennifer, et al.
Publicado: (2014)

mTOR at the Transmitting and Receiving Ends in Tumor Immunity
por: Guri, Yakir, et al.
Publicado: (2018)

Role of mTOR Signaling in Tumor Microenvironment: An Overview
por: Conciatori, Fabiana, et al.
Publicado: (2018)

Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model
por: Verreault, Maite, et al.
Publicado: (2013)

Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis
por: Farhan, Maikel A., et al.
Publicado: (2015)

STAT3 and mTOR: co-operating to drive HIF and angiogenesis
por: Dodd, Kayleigh M., et al.
Publicado: (2015)

Astemizole Inhibits mTOR Signaling and Angiogenesis by Blocking Cholesterol Trafficking
por: Lyu, Junfang, et al.
Publicado: (2018)

mTOR signalling pathway in stem cell bioactivities and angiogenesis potential
por: Lotfimehr, Hamid, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p2uptp87gum8m9klm8gefguilv